Giovanni Scambia

92PUBLICATIONS
236CO-AUTHORS
Respiratory diseasesObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Jul 24, 2025
Study design and rationale of the AZIMUTH trial: a smartphone, app-based, E-health-integrated model of care for heart failure patients.

Domenico D'Amario, Attilio Restivo, Renzo Laborante

|Mar 17, 2025
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management.

Umberto Leone Roberti Maggiore, Francesco Fanfani, Giovanni Scambia

|Oct 08, 2024
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study.

Federico Ferrari, Nicolò Bizzarri, Anna Fagotti

|Oct 04, 2024
Germline reflex BRCA1/2 testing following tumor-only comprehensive genomic profiling: why, when, and how.

Giulia Maneri, Camilla Nero, Luciano Giacò

|Sep 25, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.

Dominik Denschlag, Florian Heitz, Jacobus Pfisterer

|Sep 07, 2024
Response to: Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Aznar et al.

Giorgio Bogani, Luca Lalli, Jvan Casarin

Pageof 16